title: FDA says it's open to new approaches to cancer trials.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D000970:Antineoplastic Agents / Q000600:supply & distribution*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000379:methods; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D033161:Government Regulation; D006801:Humans; D040541:Marketing / Q000331:legislation & jurisprudence*; D009369:Neoplasms / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents